Actively Recruiting
abSorbable vErsus Non-absorbable SuturEs for Wound Closure in Carpal Tunnel Release
Led by Gelre Hospitals · Updated on 2025-08-26
2604
Participants Needed
2
Research Sites
308 weeks
Total Duration
On this page
Sponsors
G
Gelre Hospitals
Lead Sponsor
D
Deventer Ziekenhuis
Collaborating Sponsor
AI-Summary
What this Trial Is About
Carpal Tunnel Syndrome is a prevalent condition, up to 9% in women and 0.6% in men. Surgical decompression in the most effective treatment. After surgery, approximately 1,8% of the patients develop a wound infection. Possibly, the type of sutures used can influence the prevalence of wound infection. In this RCT the incidence of infection is investigated between the use of absorbable versus non-absorbable sutures in carpal tunnel release.
CONDITIONS
Official Title
abSorbable vErsus Non-absorbable SuturEs for Wound Closure in Carpal Tunnel Release
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Indication for carpal tunnel release
You will not qualify if you...
- Previous surgery for carpal tunnel syndrome
- Previous injection with corticosteroids
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Gelre Ziekenhuizen
Apeldoorn, Netherlands, 7334DZ
Actively Recruiting
2
Deventer Ziekenhuis
Deventer, Netherlands, 7416SE
Actively Recruiting
Research Team
P
Pauline Verhaegen, MD PHD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here